Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
A method of treating cancer in a subject, including: providing a subject having a plurality of cancer cells; and administering to the subject, a therapeutically effective amount of a composition including: an HDM-2 binding component; and a membrane resident component, the membrane resident component bound to the HDM-2 binding component. Also provided are a method of selectively necrosing cancer cells, a method of causing membranolysis in cancer cells, and a cancer treatment composition.
1. A method of treating cancer in a subject, said method comprising:
providing a subject having a plurality of cancer cells; and
administering to the subject, a therapeutically effective amount of a composition including:
an HDM-2 binding component comprising:
and
a membrane resident component comprising:
said membrane resident component bound to said HDM-2 binding component.
2. The method of claim 1 , further comprising the step of observing necrosis in the cancer cells.
3. The method of claim 1 , whereby the cancer cells are necrosed.